TG Therapeutics (TGTX)
Commercializes BRIUMVI while developing B-cell therapies for immune-mediated diseases.
$55.92
vs last close−2.19 (−3.77%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
$0.36
Revenue estimate
$247.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.15$0.03$0.17$2.43$0.14$0.14$0.05Pending
Estimate$0.08$0.18$0.32$0.24$0.35$0.23$0.31$0.36
Surprise+87.5%−83.3%−46.9%+912.5%−60.0%−39.1%−83.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$108.2M$120.9M$141.1M$161.7M$192.6M$204.9M$240.3MPending
Estimate$108.8M$134.2M$146.3M$193.8M$191.8M$200.3M$229.8M$247.1M
Surprise−0.6%−9.9%−3.5%−16.6%+0.4%+2.3%+4.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.56 | — | — |
| Sep 2027 | $0.72 | — | — |
| Jun 2027 | $0.62 | — | — |
| Mar 2027 | $0.50 | — | — |
| Dec 2026 | $0.47 | — | — |
| Nov 2026 | $0.36 | — | — |
| Aug 2026 | $0.31 | $0.05 | −83.6% |
| May 2026 | $0.23 | $0.14 | −39.1% |
| Feb 2026 | $0.35 | $0.14 | −60.0% |
| Nov 2025 | $0.24 | $2.43 | +912.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.56 | — | — | $369.4M | — | — | — |
| Sep 2027 | $0.72 | — | — | $335.9M | — | — | — |
| Jun 2027 | $0.62 | — | — | $311.0M | — | — | — |
| Mar 2027 | $0.50 | — | — | $281.1M | — | — | — |
| Dec 2026 | $0.47 | — | — | $263.3M | — | — | — |
| Nov 2, 2026 | $0.36 | — | — | $247.1M | — | — | — |
| Aug 3, 2026 | $0.31 | $0.05 | −83.6% | $229.8M | $240.3M | +4.6% | −11.3% |
| May 6, 2026 | $0.23 | $0.14 | −39.1% | $200.3M | $204.9M | +2.3% | +16.3% |
| Feb 26, 2026 | $0.35 | $0.14 | −60.0% | $191.8M | $192.6M | +0.4% | +4.2% |
| Nov 3, 2025 | $0.24 | $2.43 | +912.5% | $193.8M | $161.7M | −16.6% | −3.1% |
| Aug 4, 2025 | |||||||
| May 5, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 1, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 2, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 3, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 1, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 5, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 7, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |